Talon Private Wealth’s AbbVie ABBV Stock Holding History

Talon Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-49	Closed	-$8.71K	–	176
2024 Q4	$8.71K	Hold	49	–	–	﹤0.01%	228
2024 Q3	$9.68K	Buy	+49	New	+$9.14K	﹤0.01%	183

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Talon Private Wealth's ABBV Position: Q1 2025 in Review

Talon Private Wealth sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 49 shares — an estimated $8.71K sold.

Talon Private Wealth first reported a position in ABBV in Q3 2024 and held it in 2 quarters. The position peaked at $9.68K in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Talon Private Wealth reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Talon Private Wealth sold 49 AbbVie shares in Q1 2025, an estimated $8.71K.
Talon Private Wealth first reported a position in AbbVie in Q3 2024 and held it in 2 quarters.
Talon Private Wealth's AbbVie position peaked at $9.68K in Q3 2024.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Talon Private Wealth's 13F filing for Q1 2025, filed 15 May 2025.